上部交叉综合征在工作场所:一个叙述性审查与非药物管理的临床建议
Nina Hanenson Russin1, Carson Robertson2, Alicia Montalvo1
1College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA.
International journal of environmental research and public health
|January 28, 2026
概括
上部交叉综合征 (UCS) 导致肌肉失衡,导致部和肩部疼痛,特别是在计算机用户中. 早期识别和物理治疗是预防长期问题的关键.
科学领域:
- 肌肉骨系统疾病 肌肉骨系统疾病
- 运动医学运动医学
- 职业健康 职业健康 职业健康 职业健康
背景情况:
- 上部交叉综合征 (UCS) 涉及肌肉失衡,导致身体姿势不佳,如前进的头部和圆的肩膀.
- 这些姿势变化在办公室工作者中很普遍,导致严重的部和肩部疼痛.
- 由于UCS导致的计算机用户的部和肩部疼痛的患病率分别为55-69%和15-52%.
研究的目的:
- 审查UCS的流行病学和诊断.
- 综合关于UCS的物理治疗治疗方法的证据.
- 突出工作场所人体工程学和预防策略的重要性.
主要方法:
- 进行了叙事审查.
- 由行为健康博士进行的文献搜索,并由体育伤害流行病学博士审查.
- 练习的临床建议是由一个手术医生提供的.
主要成果:
- 如果不及时治疗,UCS可能会导致严重的部和肩部病理.
- 建议进行物理治疗干预以缓解症状.
- 工作站的人体工程学和定期休息对于预防至关重要.
结论:
- 早期检测和非侵入性治疗对于管理UCS至关重要.
- 医生应该识别UCS的迹象,特别是在工作场所相关的伤害.
- 了解物理治疗策略对于有效管理和预防UCS至关重要.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
777
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
777
Acute Coronary Syndrome V: Nursing Management
318
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
318
Nephrotic Syndrome II : Assessment and Medical Management
237
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
237
Nephrotic Syndrome III : Nursing Management
317
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
317
Inflammatory Bowel Disease IV: Pharmacological Management
579
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
579
Esophageal Perforation-II: Clinical Manifestations and Management
715
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
715


